TEVJF

Teva Pharmaceutical Indu... (PK) (TEVJF)

Teva Pharmaceutical Industries Ltd (PK)

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:USOTC:TEVJF

1 2 3 4 5 6 7 8 9 10 次へ >>

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/05/17	20 : 41	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/05/08	20 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/21	21 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/20	21 : 42	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/15	21 : 37	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/12	21 : 01	Edgar (US Regulatory)	Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/05	21 : 49	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/01	22 : 03	Edgar (US Regulatory)	Form SC 13G - Statement of acquisition of beneficial ownership by individuals	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/01	21 : 28	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/01	21 : 26	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/01	21 : 22	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2024/02/01	21 : 18	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/11/08	21 : 01	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/10/04	19 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/09/29	05 : 05	Edgar (US Regulatory)	Form 8-K - Current report	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 15	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 14	Edgar (US Regulatory)	Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 12	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 10	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 06	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 05	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 04	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 03	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/08	05 : 02	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/08/03	20 : 09	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/06/20	20 : 40	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/06/20	20 : 38	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)
2023/06/20	20 : 37	Edgar (US Regulatory)	Statement of Changes in Beneficial Ownership (4)	USOTC:TEVJF	Teva Pharmaceutical Industries Ltd (PK)